24 HR amphetamine 12.5 MG Extended Release Oral Tablet
- RxCUI
- 1739803
- RxNorm name
- 24 HR amphetamine 12.5 MG Extended Release Oral Tablet
- Display name
- 24 HR amphetamine 12.5 MG Extended Release Oral Tablet
- Full name
- 24 HR amphetamine 12.5 MG Extended Release Oral Tablet
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:19
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Adzenys XR-ODT | AMPHETAMINE | Neos Therapeutics Brands, LLC | c1179269-00b5-48ea-972d-31e614e99b7e | 2026-05-06 | Boxed warning, Warnings, Adverse reactions | 1739803 |
| Amphetamine Extended-Release | AMPHETAMINE EXTENDED-RELEASE | Neos Therapeutics, LP | 48d0f55c-f847-4d26-b2ed-94b5a2770228 | 2025-09-24 | Boxed warning, Warnings, Adverse reactions | 1739803 |
| Amphetamine | AMPHETAMINE | Teva Pharmaceuticals, Inc. | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2025-09-01 | Boxed warning, Warnings, Adverse reactions | 1739803 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c1179269-00b5-48ea-972d-31e614e99b7e | 24 HR amphetamine 12.5 MG Extended Release Oral Tablet | SCD | 15 | These highlights do not include all the information needed to use ADZENYS XR-ODT™ safely and effectively. See full prescribing information for ADZENYS XR-ODT. ADZENYS XR-ODT (amphetamine) extended-release orally disintegrating tablets, CII Initial U.S. Approval: 1960 | 20260506 |
| c1179269-00b5-48ea-972d-31e614e99b7e | amphetamine 12.5 MG 24 HR Extended Release Distintegrating Oral Tablet | SY | 15 | These highlights do not include all the information needed to use ADZENYS XR-ODT™ safely and effectively. See full prescribing information for ADZENYS XR-ODT. ADZENYS XR-ODT (amphetamine) extended-release orally disintegrating tablets, CII Initial U.S. Approval: 1960 | 20260506 |
| c1179269-00b5-48ea-972d-31e614e99b7e | amphetamine 12.5 MG 24HR Extended Release Distintegrating Oral Tablet | PSN | 15 | These highlights do not include all the information needed to use ADZENYS XR-ODT™ safely and effectively. See full prescribing information for ADZENYS XR-ODT. ADZENYS XR-ODT (amphetamine) extended-release orally disintegrating tablets, CII Initial U.S. Approval: 1960 | 20260506 |
| 48d0f55c-f847-4d26-b2ed-94b5a2770228 | amphetamine 12.5 MG 24 HR Extended Release Distintegrating Oral Tablet | SY | 5 | These highlights do not include all the information needed to use AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS . AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS, CII Initial U.S. Approval: 1960 | 20250924 |
| 48d0f55c-f847-4d26-b2ed-94b5a2770228 | 24 HR amphetamine 12.5 MG Extended Release Oral Tablet | SCD | 5 | These highlights do not include all the information needed to use AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS . AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS, CII Initial U.S. Approval: 1960 | 20250924 |
| 48d0f55c-f847-4d26-b2ed-94b5a2770228 | amphetamine 12.5 MG 24HR Extended Release Distintegrating Oral Tablet | PSN | 5 | These highlights do not include all the information needed to use AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS . AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS, CII Initial U.S. Approval: 1960 | 20250924 |
| 243e88e7-6621-47e9-8d5c-3f79bcb088bb | amphetamine 12.5 MG 24HR Extended Release Distintegrating Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS. AMPHETAMINE extended-release orally disintegrating tablets, CII Initial U.S. Approval: 1960 | 20250901 |
| 243e88e7-6621-47e9-8d5c-3f79bcb088bb | amphetamine 12.5 MG 24 HR Extended Release Distintegrating Oral Tablet | SY | 2 | These highlights do not include all the information needed to use AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS. AMPHETAMINE extended-release orally disintegrating tablets, CII Initial U.S. Approval: 1960 | 20250901 |
| 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 24 HR amphetamine 12.5 MG Extended Release Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for AMPHETAMINE EXTENDED-RELEASE ORALLY DISINTEGRATING TABLETS. AMPHETAMINE extended-release orally disintegrating tablets, CII Initial U.S. Approval: 1960 | 20250901 |